<VariationArchive VariationID="279841" VariationName="NM_000427.3(LORICRIN):c.684dup (p.Ser229fs)" VariationType="Duplication" Accession="VCV000279841" Version="27" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-15" DateCreated="2016-12-06" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="263978" VariationID="279841">
      <GeneList>
        <Gene Symbol="LORICRIN" FullName="loricrin cornified envelope precursor protein" GeneID="4014" HGNC_ID="HGNC:6663" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="153259687" stop="153262124" display_start="153259687" display_stop="153262124" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="153232178" stop="153234599" display_start="153232178" display_stop="153234599" Strand="+" />
          </Location>
          <OMIM>152445</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000427.3(LORICRIN):c.684dup (p.Ser229fs)</Name>
      <CanonicalSPDI>NC_000001.11:153261627:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="153261627" stop="153261628" display_start="153261627" display_stop="153261628" variantLength="1" positionVCF="153261627" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="153234103" stop="153234104" display_start="153234103" display_stop="153234104" variantLength="1" positionVCF="153234103" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>S229fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000427.2" sequenceAccession="NM_000427" sequenceVersion="2" change="c.684dupG">
            <Expression>NM_000427.2:c.684dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.153234109dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.153234109dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.153261633dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.153261633dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011818.1" sequenceAccession="NG_011818" sequenceVersion="1" change="g.6931dup">
            <Expression>NG_011818.1:g.6931dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000427.3" sequenceAccession="NM_000427" sequenceVersion="3" change="c.684dup" MANESelect="true">
            <Expression>NM_000427.3:c.684dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000418.2" sequenceAccession="NP_000418" sequenceVersion="2" change="p.Ser229fs">
            <Expression>NP_000418.2:p.Ser229fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10602758" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="152445.0001" DB="OMIM" />
        <XRef Type="rs" ID="886041212" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000427.3(LORICRIN):c.684dup (p.Ser229fs) AND not provided" Accession="RCV000368922" Version="21">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-01-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000427.3(LORICRIN):c.684dup (p.Ser229fs) AND Loricrin keratoderma" Accession="RCV002284965" Version="5">
        <ClassifiedConditionList TraitSetID="3980">
          <ClassifiedCondition DB="MedGen" ID="C1858805">Loricrin keratoderma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-20" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-12-06" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11703298</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8673107</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9326398</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3980" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5113" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Vohwinkel syndrome, variant form</ElementValue>
                <XRef ID="Vohwinkel+syndrome%2C+variant+form/9459" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Loricrin keratoderma</ElementValue>
                <XRef ID="MONDO:0011396" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VOHWINKEL SYNDROME WITH ICHTHYOSIS</ElementValue>
                <XRef Type="MIM" ID="604117" DB="OMIM" />
                <XRef Type="Allelic variant" ID="152445.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="152445.0002" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16719" />
                <XRef ID="16719" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="79395" DB="Orphanet" />
              <XRef ID="C1858805" DB="MedGen" />
              <XRef ID="MONDO:0011396" DB="MONDO" />
              <XRef Type="MIM" ID="604117" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35764" SubmissionDate="2010-10-07" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="152445.0001_VOHWINKEL SYNDROME WITH ICHTHYOSIS" title="LOR, 1-BP INS, 730G_VOHWINKEL SYNDROME WITH ICHTHYOSIS" />
        <ClinVarAccession Accession="SCV000035764" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a large kindred with Vohwinkel syndrome and ichthyosis (604117) in which linkage to the epidermal differentiation complex (EDC) region of 1q had been demonstrated, Maestrini et al. (1996) demonstrated a 1-nucleotide insertion (G) in the LOR gene after nucleotide 730 (730insG). An extra G residue was found in an area of 6 normally occurring G residues (codons 230 and 231), introducing a frameshift at codon 232 that altered the terminal 84 amino acids and produced a delayed termination codon that extended the mutant protein by 22 amino acids. Affected individuals were heterozygous for the mutation, which was not found in unaffected members of the family or in unrelated, unaffected individuals. Maestrini et al. (1996) noted that replacement of the fourth gly-rich domain and the C-terminal gln/lys-rich domain, which is thought to be involved in normal protein crosslinks, would be expected to alter the function of the protein and to impair crosslinking by transglutaminases. Since loricrin monomers become crosslinked to each other as well as to other proteins by isopeptide bonds, the defect would be expected to have a dominant-negative effect, in keeping with the autosomal dominant inheritance of the syndrome. Immunoelectron microscopy suggested to them that the mutant loricrin is abnormally or less efficiently incorporated into the cornified cell envelope and accumulates in intranuclear granules.</Attribute>
              <Citation>
                <ID Source="PubMed">8673107</ID>
              </Citation>
              <XRef DB="OMIM" ID="604117" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Korge et al. (1997) and Matsumoto et al. (2001) identified this mutation in families with variant Vohwinkel syndrome.</Attribute>
              <Citation>
                <ID Source="PubMed">9326398</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11703298</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LOR" />
          </GeneList>
          <Name>LOR, 1-BP INS, 730G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 730G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="152445.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VOHWINKEL SYNDROME WITH ICHTHYOSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="642663" SubmissionDate="2021-09-25" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:154385" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329403" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="6" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein extension, as the last 84 amino acids are replaced with 106 different amino acids, and other frameshift variants leading to a similar elongated protein have been reported in the Human Gene Mutation Database (Stenson et al. 2014); Published functional studies demonstrate that this variant form of loricrin causes the activation of various growth factor receptors and increased Akt kinase activity, resulting in the rapid keratinocyte proliferation observed in loricrin keratoderma (Yoneda et al., 2010); Not observed in large population cohorts (Lek et al., 2016); Sometimes reported using alternate nomenclature of c.730insG; This variant is associated with the following publications: (PMID: 11703298, 20635335, 31846220, 9326398, 16403113, 20236940, 8673107, 17953701, 22831754, 31595526, 32833329)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LOR" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:31345</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000427.2:c.684dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2956972" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-03-14">
        <ClinVarSubmissionID localKey="106317|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001500389" DateUpdated="2024-07-15" DateCreated="2021-03-14" Type="SCV" Version="20" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LORICRIN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="AG" referenceAllele="A" start="153234103" stop="153234103" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7127288" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="d29fb35589751928b6efac8ae43a2aa993b66166de0fc98f662638596b8a6325|OMIM:604117" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003823401" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000427.3:c.684dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604117" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="35764" TraitType="Disease" MappingType="Name" MappingValue="VOHWINKEL SYNDROME WITH ICHTHYOSIS" MappingRef="Preferred">
        <MedGen CUI="C1858805" Name="Loricrin keratoderma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="642663" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2956972" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7127288" TraitType="Disease" MappingType="XRef" MappingValue="604117" MappingRef="OMIM">
        <MedGen CUI="C1858805" Name="Loricrin keratoderma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

